Otte A - Search Results

1

Interference of Ca²⁺ with the proliferation of SCCOHT-1 and ovarian adenocarcinoma cells.

Otte A, Rauprich F, von der Ohe J, Hillemanns P, Hass R. Otte A, et al. Int J Oncol. 2014 Sep;45(3):1151-8. doi: 10.3892/ijo.2014.2518. Epub 2014 Jun 24. Int J Oncol. 2014. PMID: 24969518

2

A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type.

Otte A, Göhring G, Steinemann D, Schlegelberger B, Groos S, Länger F, Kreipe HH, Schambach A, Neumann T, Hillemanns P, Park-Simon TW, Hass R. Otte A, et al. Int J Oncol. 2012 Aug;41(2):765-75. doi: 10.3892/ijo.2012.1468. Epub 2012 May 8. Int J Oncol. 2012. PMID: 22581215

3

In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model.

Otte A, Rauprich F, Hillemanns P, Park-Simon TW, von der Ohe J, Hass R. Otte A, et al. Orphanet J Rare Dis. 2014 Aug 8;9:126. doi: 10.1186/s13023-014-0126-4. Orphanet J Rare Dis. 2014. PMID: 25103190 Free PMC article.

4

Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines.

Yang Y, Otte A, Hass R. Yang Y, et al. Among authors: otte a. Stem Cells Dev. 2015 May 15;24(10):1205-22. doi: 10.1089/scd.2014.0413. Epub 2015 Jan 26. Stem Cells Dev. 2015. PMID: 25525832 Free PMC article.

5

Acquisition of new tumor cell properties by MSC-derived exosomes.

Yang Y, Bucan V, Baehre H, von der Ohe J, Otte A, Hass R. Yang Y, et al. Among authors: otte a. Int J Oncol. 2015 Jul;47(1):244-52. doi: 10.3892/ijo.2015.3001. Epub 2015 May 11. Int J Oncol. 2015. PMID: 25963929

6

c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.

Otte A, Rauprich F, von der Ohe J, Yang Y, Kommoss F, Feuerhake F, Hillemanns P, Hass R. Otte A, et al. Oncotarget. 2015 Oct 13;6(31):31640-58. doi: 10.18632/oncotarget.5151. Oncotarget. 2015. PMID: 26436697 Free PMC article.

7

SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.

Otte A, Yang Y, von der Ohe J, Melzer C, Hillemanns P, Feuerhake F, Hass R. Otte A, et al. Int J Oncol. 2016 Dec;49(6):2453-2463. doi: 10.3892/ijo.2016.3735. Epub 2016 Oct 14. Int J Oncol. 2016. PMID: 27748897

8

Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment.

Hass R, Otte A. Hass R, et al. Among authors: otte a. Cell Commun Signal. 2012 Sep 3;10(1):26. doi: 10.1186/1478-811X-10-26. Cell Commun Signal. 2012. PMID: 22943670 Free PMC article.

9

Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo.

Mandel K, Yang Y, Schambach A, Glage S, Otte A, Hass R. Mandel K, et al. Among authors: otte a. Stem Cells Dev. 2013 Dec 1;22(23):3114-27. doi: 10.1089/scd.2013.0249. Epub 2013 Sep 9. Stem Cells Dev. 2013. PMID: 23895436

10

Conditioned umbilical cord tissue provides a natural three-dimensional storage compartment as in vitro stem cell niche for human mesenchymal stroma/stem cells.

Yang Y, Melzer C, Bucan V, von der Ohe J, Otte A, Hass R. Yang Y, et al. Among authors: otte a. Stem Cell Res Ther. 2016 Feb 11;7:28. doi: 10.1186/s13287-016-0289-0. Stem Cell Res Ther. 2016. PMID: 26869167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters